Oscar Best Picture Winner ‘Oppenheimer’ Is No. 5 In Deadline’s 2023 Most Valuable Blockbuster Tournament
01.05.2024 - 20:45
/ deadline.com
Deadline’s Most Valuable Blockbuster tournament is back. While studios during Covid wildly embraced the theatrical day-and-date model when cinemas were closed, they soon realized there’s nothing more profitable than a theatrical release and the downstreams that come with it. If anything, theatrical is the advertisement for a movie’s longevity in subsequent home entertainment windows. Entering the conversation in 2023 were the streamers, such as Apple, who have also realized the necessity of theatrical to eventize their movies. The financial data pulled together here for Deadline’s Most Valuable Blockbuster Tournament is culled by seasoned and trusted sources.
Oppenheimer
Universal
Following Warner Bros’ Covid release of Tenet and the studio’s then-aggressive pivot to a theatrical day-and-date distribution model on Max, Christopher Nolan shopped his next project, the World War II-set Oppenheimer, to rival studios. Universal snapped at the opportunity to take on the $100 million production., thought on paper it was a risky bet to get behind a three-hour, dialogue-heavy biopic about a nuclear physicist. No one, not even the studio, saw the pic’s near-$1 billion global gross coming.
Universal honored Nolan’s wishes to open Oppenheimer on the filmmaker’s good-luck weekend — the third frame in July, where he’s bowed such blockbusters as his last two Dark Knight movies and Dunkirk. The studio didn’t flinch when Warner Bros dated Barbie on top of Oppeneheimer; Uni had all the Imax screens since Nolan had shot black-and-white footage in the large format, a first for Imax. Universal didn’t market Oppenheimer as merely guys counterprogramming to Barbie‘s en masse girls. Rather, they sold it as a movie for everybody, and Nolan
The website celebfans.org is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can
send a complaint on the news if you find it unreliable.